factual

Roto-Rooter and VITAS Compound Earnings Near 20% Overall

Combined with buybacks, Chemed's EPS grows about 20-21% a year and its stock compounded at a similar rate over 21 years, a result Chadd attributes to low-single-digit revenue growth, low-double-digit earnings growth, and share repurchases.

factualpending

Speaker

Chadd

Evidence Quote

“when you combine it at a corporate level and you layer in all the share repurchases they have, their EPS grows about 20-21% and their stock price over the last 21 years has compounded about the same rate.”

Source

Chemed: Empire of Care— Business Breakdowns
Created: 11/18/2026, 12:19:50 PM

Your notes

Loading notes...